Dicerna Pharmaceuticals, Inc
Novo Nordisk Inc. is a global healthcare company dedicated to driving change in caring for patients with diabetes and other chronic diseases. They focus on innovation, sustainability, diversity, equity, inclusion, and community support to improve health outcomes worldwide.
Industries
Nr. of Employees
large (251-1000)
Dicerna Pharmaceuticals, Inc
800 Scudders Mill Road, Plainsboro, NJ 08536
Patents
Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA
US-11773390-B2
View DetailsMethods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
US-11697812-B2
View Details
Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA
US-11773390-B2
View DetailsMethods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
US-11697812-B2
View DetailsProducts
Therapeutics for diabetes
Pharmaceutical therapies indicated for the treatment and management of diabetes.
Therapeutics for obesity
Pharmaceutical therapies indicated for the treatment and management of obesity.
Rare disease therapeutics
Therapies developed for rare and orphan diseases, including treatments for hemophilia and other rare bleeding disorders.
Injection delivery devices and accessories
Delivery devices and associated consumables intended to facilitate accurate subcutaneous administration of injectable therapies.
Clinical genetic testing service
A targeted genetic testing service intended to support diagnosis and therapeutic decision-making.
Therapeutics for diabetes
Pharmaceutical therapies indicated for the treatment and management of diabetes.
Therapeutics for obesity
Pharmaceutical therapies indicated for the treatment and management of obesity.
Rare disease therapeutics
Therapies developed for rare and orphan diseases, including treatments for hemophilia and other rare bleeding disorders.
Injection delivery devices and accessories
Delivery devices and associated consumables intended to facilitate accurate subcutaneous administration of injectable therapies.
Clinical genetic testing service
A targeted genetic testing service intended to support diagnosis and therapeutic decision-making.
Services
Review and potential support for investigator-initiated studies and related scientific collaboration.
Provision of medical writing support through third-party agencies and performance of medical accuracy review prior to submission.
Mechanisms to review and provide investigational therapies to eligible patients under predefined expanded access pathways.
Online supplier registration, evaluation, and contracting processes to onboard diverse and minority-owned suppliers.
Digital education portals, patient support solutions, and multilingual conversational agents to support disease education and self-management.
Management of contract partner relationships and trading partner coordination to support distribution and commercial operations.
Review and potential support for investigator-initiated studies and related scientific collaboration.
Provision of medical writing support through third-party agencies and performance of medical accuracy review prior to submission.
Mechanisms to review and provide investigational therapies to eligible patients under predefined expanded access pathways.
Online supplier registration, evaluation, and contracting processes to onboard diverse and minority-owned suppliers.
Digital education portals, patient support solutions, and multilingual conversational agents to support disease education and self-management.
Management of contract partner relationships and trading partner coordination to support distribution and commercial operations.
Expertise Areas
- Clinical trial management
- Bioprocessing and biologics manufacturing
- Regulatory compliance and transparency reporting
- Market access and reimbursement strategy
Key Technologies
- Fermentation-based bioprocessing
- Recombinant protein expression
- Cell therapy platforms
- Clinical genetic/molecular diagnostic testing
News & Updates
Presentation of studies with semaglutide and CagriSema, expanding evidence in obesity and diabetes care.
Reinforcing commitment to research in rare blood disorders.
Partnership to raise awareness and support for obesity.
Recognition for leadership and innovation
Numerous awards including PharmaVoice 100, Women of Color in Pharma’s Visionary Award, and others.
Presentation of studies with semaglutide and CagriSema, expanding evidence in obesity and diabetes care.
Reinforcing commitment to research in rare blood disorders.
Partnership to raise awareness and support for obesity.
Recognition for leadership and innovation
Numerous awards including PharmaVoice 100, Women of Color in Pharma’s Visionary Award, and others.